Login  | Join

The Polypill in the Prevention of Cardiovascular Diseases

dianagosalvez Diana Gosálvez Prados last modified 5/10/2012 11:32

Key Concepts, Current Status, Challenges, and Future Directions

Lonn E, Bosch J, Teo KK, Pais P, Xavier D, Yusuf S. The Polypill in the Prevention of Cardiovascular Diseases. Circulation. 2010; 122: 2078-2088. Available at: http://circ.ahajournals.org/content/122/20/2078


Article

5/10/2012

Cardiovascular disease (CVD) is the major cause of death and disability globally and affects approximately half of all individuals over their lifetimes.The CVD burden has decreased in developed countries as effective prevention and treatment strategies were implemented,although these gains are threatened by increasing obesity, sedentary lifestyles, and diabetes mellitus. By contrast, CVD has increased in developing countries, and by the year 2020, 80% of the global CVD mortality is predicted to occur in low- and middle-income countries.


Lonn E, Bosch J, Teo KK, Pais P, Xavier D, Yusuf S.

Norte América
Prevention and health promotion Collaborative document
Countering non-communicable disease through innovation Publications